Quoin Pharmaceuticals Ltd ADR QNRX

$4.50 -0.05 (-1.10%)

Valuation

Market cap
9,038,000
Revenue TTM
$0
Net income TTM
$-15,800,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
42,500
Avg volume
689,296
Day's range
$4.25 – $4.68
Shares out
2,008,000
Stochastic %K
20%
Beta
1.56
Analysts
Strong Sell
Price target
$20.20

Price

Company profile

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It...

Show more

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.

Industry
Biotechnology
Sector
Healthcare
Phone
703 980 4182
Website
https://quoinpharma.com
Address
42127 Pleasant Forest Court, Ashburn, United States

Latest news

Stocktwits

DipBuyPro Oct 9, 9:26 PM
If you like to find the runners early - Join the group of bulls below One of the best FREE small cap communities i know of 🔥 🫡💯 Banger play on $QNRX $XRTX now
0 replies
WhoDoneIt69 Oct 5, 7:06 PM
$QNRX -26% s
0 replies
MingChoo Sep 30, 12:08 AM
$QNRX who remember when this ran feom 8>21$ last year. hopefully another similar run comes along
0 replies
InfiniteSpace Sep 24, 3:37 PM
$QNRX love seeing the price target at $20. I’m still holding shares at $50
1 replies
MrTicker Sep 23, 2:24 PM
$QNRX Lake Street Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $20 BENZINGA 9:23 AM ET 9/23/2026 Lake Street analyst Thomas Flaten initiates coverage on Quoin Pharmaceuticals(QNRX) with a Buy rating and announces Price Target of $20.
0 replies
MrTicker Sep 22, 12:34 PM
$QNRX Quoin Pharmaceuticals Says FDA Granted Fast Track Designation To QRX003 For Peeling Skin Syndrome BENZINGA 7:33 AM ET 9/22/2026
0 replies
MrTicker Sep 22, 12:32 PM
$QNRX Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome GLOBENEWSWIRE 7:30 AM ET 9/22/2026
0 replies
Stock_Catcher Sep 22, 12:30 PM
$QNRX Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
0 replies